SPC256
Duzallo - allópúrínól/lesinurad eða lyfjafræðiilega tækt salt eða sölt þess
Status:
AfskrifuðApplication date:
20.2.2019Application published:
15.3.2019
Medicine name:
DuzalloMedicine for children:
No
Timeline
Today
20.2.2019Application
15.3.2019Publication
Marketing license
Foreign authorization number:
EU/1/18/1300Date:
23.8.2018
Owner
Name:
Ardea Biosciences, Inc.Address:
9390 Towne Centre Drive, San Diego US
Agent
Name:
Kjartan Ragnars, hrl.Address:
Hrauntungu 66, 200 Kópavogi
Patent
Number:
EP2217577